Loading asset research
Evolus Inc. Common Stock
EOLSNasdaq · USD · StocksQuote as of · Exchange session not verified$7.83
-1.01%
Today
EOLS
Loading 1D prices…
Market cap
$517.8M
Volume
586.5K
52w high
$9.3152w low
$3.86Company profile
Evolus Inc. Common Stock
Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels, which includes various products, such as mid face, nasolabial folds, lips and eyes. The company was incorporated in 2012 and is headquartered in Newport Beach, California.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
Newport Beach, CA, United States
Employees
353
Fiscal year end
1231
CIK
1570562
Session & valuation
Open$8.01
Previous close$7.91
Day high$8.15
Day low$7.81
30-day avg. volume1.1M
Outstanding shares66.1M
Diluted EPS-$0.80
Latest annual period
P/E (trailing)-9.79
P/E (forward)28.41
Price / book-16.75
Beta1.43
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| OVIDOvid Therapeutics Inc. Common Stock | $525.4M | $7.3M | -239.93% | -$0.23 | +1.90% | Buy |
| IRDOpus Genetics Inc. Common Stock | $502.5M | $14.2M | -349.33% | -$0.80 | -0.49% | Buy |
| ARVNArvinas Inc. Common Stock | $545.2M | $262.6M | -30.85% | -$1.14 | -2.99% | Hold |
| CAPRCapricor Therapeutics Inc. Common Stock | $486.6M | $0.00 | — | -$2.26 | +0.90% | Hold |
| VOGXVogenx Inc Common Stock | $485.9M | $0.00 | — | -$0.2874 | +9.54% | Buy |